Orlistat (Nipocut (120 mg)) is a lipase inhibitor, prescribed for obesity in adults. It works by blocking the digestion of fats from the diet. The information provided on this page is intended to ...
February 3, 2010 — A randomized placebo controlled trial of orlistat (Alli, GlaxoSmithKline) 60 mg daily for overweight to obese but otherwise healthy subjects showed that the weight-loss agent was ...
You don’t have to be a registered dietitian to know that eating healthy and working out are clutch for losing weight. But that doesn’t mean there aren't a lot of people still hoping a medicine or ...
Orlistat, an inhibitor of gastrointestinal fat absorption used for promoting weight loss in adults, was approved for use in adolescents in 2003, partly based on results from this randomized trial. The ...
FDA Approves Alli(TM) (orlistat 60 Mg Capsules) Over-The-Counter GlaxoSmithKline Consumer Healthcare announces today that the U.S. Food and Drug Administration (FDA) approved the weight-loss product ...
Alli (orlistat) is an over-the-counter medication used to help people lose weight. Studies have shown that Alli can help people lose more weight than dieting alone. The weight loss drug is intended ...
In a recent study published in The American Journal of Clinical Nutrition, researchers compared the effects of an experimental low-carbohydrate and high-protein diet and orlistat with that of a ...
Excess visceral adipose tissue is an important predictor of metabolic risk factors for coronary artery disease. Orlistat is a weight-loss drug (taken in conjunction with a reduced-calorie, low-fat ...
The aim of this study is to review the clinical and economic rationale for the reimbursement of orlistat in responding obese patients with type 2 diabetes. Data from seven randomized controlled ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Orlistat (Olisat (60 mg)) is a lipase inhibitor, ...
Americans will soon have a new weight loss option available on the market. The FDA has announced the approval of orlistat (Alli, GlaxoSmithKline) 60-mg capsules, for over-the-counter use in the United ...
TOKYO, Jan. 13, 2009-Taisho Pharmaceutical (Taisho) has reached an agreement with Glaxo Group Limited, a subsidiary of GlaxoSmithKline (GSK) plc [Headquarters: U.K.; CEO: Andrew Witty] to grant Taisho ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results